- Home
- ADXN vs EVOK Comparison
ADXN vs EVOK Comparison
Compare ADXN & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- EVOK
- Stock Information
- Founded
- ADXN 2002
- EVOK 2007
- Country
- ADXN Switzerland
- EVOK United States
- Employees
- ADXN N/A
- EVOK N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- EVOK Health Care
- Exchange
- ADXN Nasdaq
- EVOK Nasdaq
- Market Cap
- ADXN 8.1M
- EVOK 4.2M
- IPO Year
- ADXN N/A
- EVOK 2013
- Fundamental
- Price
- ADXN $9.38
- EVOK $2.72
- Analyst Decision
- ADXN Strong Buy
- EVOK
- Analyst Count
- ADXN 1
- EVOK 0
- Target Price
- ADXN $30.00
- EVOK N/A
- AVG Volume (30 Days)
- ADXN 17.4K
- EVOK 19.3K
- Earning Date
- ADXN 08-11-2025
- EVOK 08-12-2025
- Dividend Yield
- ADXN N/A
- EVOK N/A
- EPS Growth
- ADXN N/A
- EVOK N/A
- EPS
- ADXN 0.10
- EVOK N/A
- Revenue
- ADXN $278,508.00
- EVOK $11,594,083.00
- Revenue This Year
- ADXN $86.57
- EVOK $57.82
- Revenue Next Year
- ADXN N/A
- EVOK $59.12
- P/E Ratio
- ADXN $0.76
- EVOK N/A
- Revenue Growth
- ADXN N/A
- EVOK 89.89
- 52 Week Low
- ADXN $6.51
- EVOK $1.94
- 52 Week High
- ADXN $13.27
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- ADXN 58.19
- EVOK 43.42
- Support Level
- ADXN $8.50
- EVOK $2.50
- Resistance Level
- ADXN $9.87
- EVOK $2.84
- Average True Range (ATR)
- ADXN 0.78
- EVOK 0.20
- MACD
- ADXN 0.05
- EVOK -0.01
- Stochastic Oscillator
- ADXN 72.46
- EVOK 47.45
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.